Jan. 27 Business Watch: Vioneo moves project to China; GSK to buy Rapt Therapeutics for $2.2 billion
Of the many options, the most satisfying in the opinion of C&EN’s business team is calcium chloride. The chemical is strongly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results